Dr. Chintan H. Mehta, MD

Dr. Mehta practices at HonorHealth John C. Lincoln Medical Center in Phoenix, Arizona, part of HonorHealth.

Dr. Mehta's NPI, 1528082849, was assigned on July 27, 2006. Dr. Mehta holds Arizona license 35697.

Dr. Mehta's primary practice is HonorHealth John C. Lincoln Medical Center, at 250 East Dunlap Avenue, Phoenix, AZ 85020 in Maricopa County. The practice phone is (602) 943-2381.

Dr. Mehta's primary practice is HonorHealth John C. Lincoln Medical Center in Phoenix, Arizona, part of HonorHealth. The medical group on file is Affiliated Hospitalists (Affiliated Health Partners). Dmand AI also links Dr. Mehta to 2 more hospices and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 4 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Mehta is licensed in Arizona.

CMS data shows 1,665 Medicare services from Dr. Mehta across 11 procedure codes in 2024, for 207 Medicare patients. Medicare paid $151,122 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 207 Medicare patients who saw Dr. Mehta in 2024. The largest group is 75 to 84, with 81 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 72, with 51% women.

In 2024, Dr. Mehta wrote 2,688 Medicare Part D claims for 274 patients. 88% of them were for generic drugs. CMS names the drug for 2,058 of them, across 69 drugs with 11 or more claims each, at $58,594 in total drug cost. In 2023, CMS named 2,666 claims across 70 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Mehta for performance year 2024, reported as part of a group. Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Mehta. The most frequent topics are Drug Discovery and Software. Dr. Mehta has published most often in Nucleic Acids Res.

CMS Open Payments shows 29 general payments to Dr. Mehta from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $375.